Comparison of the Journey II bicruciate stabilised (JII-BCS) and GENESIS II total knee arthroplasty for functional ability and motor impairment: the CAPAbility, blinded, randomised controlled trial
Objectives To determine if a newer design of total knee replacement (TKR) (Journey II BCS) produces superior patient-reported outcomes scores and biomechanical outcomes than the older, more established design (Genesis II).Setting Patients were recruited from an NHS University Hospital between July 2...
Saved in:
| Main Authors: | Allan B Clark, Toby O Smith, J Wells, Iain McNamara, Juliet High, Ann Marie Swart, Valerie Pomeroy, Graham Creelman, Celia Whitehouse, B Harry, Celia Clarke |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2023-01-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/13/1/e061648.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Study of the Influence of Pharmaceutical Excipients on the Solubility and Permeability of BCS Class II Drugs
by: Vivien Bárdos, et al.
Published: (2025-04-01) -
DISSOLUTION PROFILE STUDIES OF BCS CLASS II DRUG VALSARTAN BY BIOWAIVER PROCEDURE
by: E. R. Brigas, et al.
Published: (2019-01-01) -
Appropriate flexion gap evaluation for fine-tuning of medial stabilizing technique in JOURNEY II bicruciate stabilized total knee arthroplasty
by: Yukio Akasaki, et al.
Published: (2025-09-01) -
Spontaneous nanoemulsification for solubility enhancement of BCS class II and IV molecules, quercetin as a model drug
by: Marwan Motuq Alsufyani, et al.
Published: (2025-06-01) -
Clinical outcomes and biomechanics in bicruciate‐retaining total knee arthroplasty
by: Kenichi Kono, et al.
Published: (2025-01-01)